Skip to content

Opening book details…

About this Medicine article

A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer by Pignata, S.; Varriale, E.; Casella, G.; Iodice, F.; De Placido, G.; Perrone, F.; Tramontana, F.; Ricchi, P.; De Vivo, R.; Costanzo, R.; Vernaglia, A.; Tramontana, S. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Pignata, S.; Varriale, E.; Casella, G.; Iodice, F.; De Placido, G.; Perrone, F.; Tramontana, F.; Ricchi, P.; De Vivo, R.; Costanzo, R.; Vernaglia, A.; Tramontana, S.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2000
Language
EN
Field
Medicine (Health Sciences)

More by Pignata, S.; Varriale, E.; Casella, G.; Iodice, F.; De Placido, G.; Perrone, F.; Tramontana, F.; Ricchi, P.; De Vivo, R.; Costanzo, R.; Vernaglia, A.; Tramontana, S.

Browse all works by Pignata, S.; Varriale, E.; Casella, G.; Iodice, F.; De Placido, G.; Perrone, F.; Tramontana, F.; Ricchi, P.; De Vivo, R.; Costanzo, R.; Vernaglia, A.; Tramontana, S.